Markets

Sage Therapeutics craters 64% after failing a key trial for its depression drug

Shares of Sage Therapeutics, a Cambridge-based pharmaceutical company, cratered almost 64% on Thursday morning. The crash came after the drugmaker – which focuses on brain disorders – reported disappointing study results for a key depression treatment. The trial showed that patients who took the drug didn’t see more relief compared […]
Sage Therapeutics craters 64% after failing a key trial for its depression drug
News

Dispensed: What we saw at JPMorgan’s big healthcare investor conference

Hello, It’s been a long, exciting albeit tiring week for the healthcare team as we made our way around San Francisco’s Union Square during the J.P. Morgan Healthcare Conference. Hills were climbed, cricket tacos consumed, and healthcare discussed at length. Many, many stories ahead from those conversations. But to start, […]
Dispensed: What we saw at JPMorgan’s big healthcare investor conference